Mission
Our mission is to dedicate itself to creating new value, not only for science, but for human life and culture through our bio-imaging technologies.
Amalgaam’s Overview
Amalgaam is a biotechnology company that has been established in 2003, and developing novel fluorescent proteins in collaboration with Dr. Atsushi Miyawaki at RIKEN in Japan.
With our novel fluorescent proteins, we contributed to the development of novel research tools (e.g. Cell-cycle indicator “Fucci” developed by Dr. Sakaue-Sawano at RIKEN and “Fluo-chase” for protein complementation assay) and a genetically modified “Fuorescent silk fiber” (joint project with the Ministry of Agriculture, Forestry and Fisheries, etc.).
We are continuously challenging to the discovery and development of novel fluorescent proteins and bio-imaging technologies.
Amalgaam’s Major Partners
- Academia (worldwide)
- Pharmaceutical companies (including Bio-tech companies)
- Other industries (Food, etc.)
Company Outline
| Company Name | Amalgaam Co., Ltd. |
| Location | Location 2-9-3 Itabashi, Itabashi-ku, Tokyo 173-0004 JAPAN, +81-3-5943-2311 |
| President and CEO | Shinji Tsujii Ph. D. |
| Foundation | January 20, 2003 |
| Capital | 3 million yen |
| Number of employee | 4 (As of Sep. 2010) |
